Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paine

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavirStéphane J Mouly, Mary F Paine, Paul B Watkins
Therapeutic Drug Monitoring|September 24, 2004
New insights into drug absorption: studies with sirolimusMary F Paine, Louis Y Leung, Paul B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazoleM F Paine, P Schmiedlin-Ren, P B Watkins
Pharmacology & Therapeutics|August 14, 2012
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transportChristina S Won, Nicholas H Oberlies, Mary F Paine
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2004
Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibitionMary F Paine, Anne B Criss, Paul B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2004
Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding propertiesMary F Paine, Anne B Criss, Paul B Watkins
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2010
Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytesJin Kyung Lee, Mary F Paine, Kim L R Brouwer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2020
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450Sumit Bansal, Neha Maharao, Mary F Paine, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?Sompon Wanwimolruk, Mary F Paine, Susan N Pusek, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarinsS Malhotra, D G Bailey, M F Paine, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavirStéphane J Mouly, Mary F Paine, Paul B Watkins
Therapeutic Drug Monitoring|September 24, 2004
New insights into drug absorption: studies with sirolimusMary F Paine, Louis Y Leung, Paul B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazoleM F Paine, P Schmiedlin-Ren, P B Watkins
Pharmacology & Therapeutics|August 14, 2012
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transportChristina S Won, Nicholas H Oberlies, Mary F Paine
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2004
Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibitionMary F Paine, Anne B Criss, Paul B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2004
Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding propertiesMary F Paine, Anne B Criss, Paul B Watkins
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2010
Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytesJin Kyung Lee, Mary F Paine, Kim L R Brouwer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2020
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450Sumit Bansal, Neha Maharao, Mary F Paine, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?Sompon Wanwimolruk, Mary F Paine, Susan N Pusek, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarinsS Malhotra, D G Bailey, M F Paine, et al.
Pageof 18